Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenstrom macroglobulinemia: final analysis of a phase 2 study

出版年份 2015 全文链接

标题

作者

关键词

出版物

Volume 126, Issue 11, Pages 1392-1394

出版商

American Society of Hematology

发表日期

2015-09-11

DOI

10.1182/blood-2015-05-647420

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now